top-virology-solution-companies-in-europe - virology-tech-europe Companies

Pharma Tech Outlook: Pharma Tech Magazine

Leukocare AG: Liquid Drug Formulation Bolstered by AI

Top 10 Virology Solution Companies in Europe - 2021


New, more harmful pathogenic viruses with different mutations continue to emerge or resurface across the world, posing severe threats to humanity. The aftermath of COVID-19 only strengthened this ever-prevalent hypothesis, with virologists facing a herculean task in assisting frontline workers, caregivers, doctors, and more. Evidently, studying a virus and subsequently developing antiviral medicines and vaccines is the need of the hour in order to improve the efficacy of care. To this end, several virologists are stepping up to assist medical caregivers with new methodologies and technologies that catalyse the production of vaccines for faster, easier, and more consistent results.

Several new approaches have already yielded results, as seen by the newer vaccinations and diagnostics being developed by various firms to help humanity contain the Covid-19 catastrophe. However, it is difficult for virologists to simply design a vaccine; they must first research and comprehend the viral structure, which is a difficult process. And, as new viruses are discovered, virologists are forced to attempt alternative ways to find a treatment, which leads to the development of novel technologies.

At this juncture, there is a broad spectrum of virology solution providers entering the industry with a set of advanced and integrated offerings. To help healthcare organizations navigate the best-of-breed solution providers, Pharma Tech Outlook Europe has compiled a list of the leading players in the field. This edition also offers a combination of thought-leadership insights from subject-matter experts and real-life stories on nurturing robust partnerships among healthcare stakeholders. We hope this edition will provide you with the proper assistance in choosing the best virology tech solution providers and service companies according to your requirements.

We present to you Pharma Tech Outlook Europe’s” Top 10 Virology Solution Providers 2021”.

    Top Virology Solution Companies in Europe

  • Cepheid set the bar for innovation in automated molecular diagnostics more than a decade ago, and we've never looked back. Cepheid is continually developing and improving its capabilities, while having the biggest installed base of any molecular platform. Healthcare executives across the world have hailed the GeneXpert® System as a game-changer because it allows institutions of all sizes, from tiny medical clinics to high-volume reference labs and hospitals, to access the speed and precision of molecular diagnostics.Cepheid's expanding Xpert® test range includes tests for healthcare-associated infections, sexual health, critical infectious illness, virology, and cancer, among other clinical applications

  • GeneProof is a biotechnology company operating in the field of molecular in vitro diagnostics of serious infections and genetic diseases. Under the leadership of Chairman and CEO Radek Horvath, GeneProof develops, produces, and distributes technologically advanced, high quality, user-friendly, and affordable PCR products. What differentiates GeneProof from other contemporary solution providers is the company’s extensive experience in the areas of automation PCR testing and laboratory workflow. Having helped countless clients overcome their laboratory workflow problems, GeneProof understands the typical challenges laboratories face with clinical samples, and as such, GeneProof tries to resolve these hurdles proactively for its clients. In addition to that GeneProof offers a suite of additional solutions including a semi-automated and fully automated PCR system to help laboratories not only meet clinical targets but to surpass them

  • Being a leading supplier of functional cell-based assays and advanced products for cellular microscopy, ibidi provides an innovative surface technology that can be used to arrange adherent cells in regular (micro) patterns, either individually or in small groups. This enables the researcher to simultaneously visualize the influence of drugs and viruses on the cells. The functional assays provide characteristic parameters that can be easily quantified. At the same time, these parameters often depend on complex metabolic processes within the cells. This makes it possible to sensitively measure the influence of disturbances caused, for example, by chemicals, bacteria and viruses

  • Leukocare AG, located in Martinsried/Munich, Germany and Milford, MA, USA, is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence

  • AiCuris


    AiCuris is a pharmaceutical firm focused on the discovery, research, and development of new, resistance-busting antiviral and antibacterial medicines for the treatment of severe and sometimes fatal infectious illnesses. AiCuris, a spinoff from Bayer Infection Research, was founded in 2006 and now maintains an innovative pipeline of anti-infective medicines with a team of globally known experts in Research and Development. We are one of the few European biotech firms that have successfully commercialised a medication with “blockbuster” potential (Prevymis® 2017/18)

  • Cerba Research

    Cerba Research

    Cerba Research has been establishing the industry standard for excellent clinical trial conduct for over 35 years. Today, we are redefining the paradigm of the central lab's involvement in complicated clinical research spanning five continents, with an emphasis on precision medicine. Our enthusiastic specialists provide the highest quality specialised and tailored laboratory and diagnostic solutions from protocol creation through development and commercialization. Join up with us to develop the most effective approach for bringing your biotech and pharmaceutical products to market faster and improving the lives of people all around the world

  • ELITechGroup


    ELITechGroup is a privately held company that produces and distributes in vitro diagnostic equipment and reagents all over the world. ELITechGroup has been a key contributor in expanding clinical diagnostics to laboratories in the proximity market, those operating closer to the patient, by bringing together IVD specialised firms that offer new products and solutions. Through direct sales and a distribution network spanning more than 100 countries, ELITechGroup develops and sells diagnostic products for clinical chemistry, microbiology, haematology, and molecular biology

  • Mobidiag


    Mobidiag, A Hologic Company, is a rapidly expanding Finnish-French biotech firm. Mobidiag is a molecular diagnostics company that specialises in gastrointestinal infections, antimicrobial resistance management, healthcare-associated infections (HAIs), respiratory infections, and sepsis. Mobidiag offers a wide range of assays and automated platforms based on well-established qPCR and microarray technologies. These include a wide range of rapid, dependable, and cost-effective molecular diagnostic tools for infectious disease detection suited to laboratories of all sizes.They are capable to detecting the majority of clinically important bacteria, parasites, viruses, and antibiotic resistances

  • Myriade


    Myriade is a French company created in 2017 that develops an innovative nanoscale imaging technology. Myriade was born from the partnership between Quattrocento (Company builder, specialized in equipments for life sciences), Paris Sciences et Lettres, and the scientific team

  • Yposkesi


    Yposkesi is a full-service CDMO, providing professional support through all stages of gene therapy development. We make available the entire viral vector manufacturing services necessary to enable you to rapidly and successfully develop ATMPs. You gain access to specialized expertise with integrated project management as well as streamlined and cost-efficient bioprocess development services